Concepedia

Louise Kelly

LK

Statistics

Publications

20

Citations

1.9K

H-Index

16

Active since

2000

Affiliations

University of La Verne(Current)

St. Vincent's University Hospital

Alliant International University

Middle East University

University College Dublin

Louise Kelly is an author at University of La Verne specializing in leadership, oncology, and business.

Publications per year

2000–2022

20

Publications

20

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412

Ellen Weisberg, Christina Boulton, Louise Kelly et al. · Cancer Cell · 2002 · 602 citations · Full text

Medicine, Oncology, Pharmacology +14

Founder Centrality and Strategic Behavior in the Family-Owned Firm

Louise Kelly, Nicholas Athanassiou, William F. Crittenden · Entrepreneurship Theory and Practice · 2000 · 369 citations

Business, Strategic Management, Strategy +17

The role of CEO transformational leadership and innovation climate in exploration and exploitation

Abdelrahman Zuraik, Louise Kelly · European Journal of Innovation Management · 2018 · 250 citations

Management, Leadership, Organizational Behavior +12

Founder centrality effects on the Mexican family firm’s top management group: firm culture, strategic vision and goals, and firm performance

Nicholas Athanassiou, William F. Crittenden, Louise Kelly et al. · Journal of World Business · 2002 · 149 citations · Full text

Business, Strategic Management, Strategy +16

The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3

Karsten Spiekermann, Ralf J. Dirschinger, Ruth Schwab et al. · Blood · 2003 · 115 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

1–5 of 20